title: PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
abstract: Genes involved in the inflammation pathway have been associated with cancer risk. Genetic variants in the interleukin-6 (IL6) and prostaglandin-endoperoxide synthase-2 (PTGS2, encoding for the COX-2 enzyme) genes, in particular, have been related to several cancer types, including breast and prostate cancers. We conducted a study within the Breast and Prostate Cancer Cohort Consortium to examine the association between IL6 and PTGS2 polymorphisms and breast and prostate cancer risk. Twenty-seven polymorphisms, selected by pairwise tagging, were genotyped on 6292 breast cancer cases and 8135 matched controls and 8008 prostate cancer cases and 8604 matched controls. The large sample sizes and comprehensive single nucleotide polymorphism tagging in this study gave us excellent power to detect modest effects for common variants. After adjustment for multiple testing, none of the associations examined remained statistically significant at P = 0.01. In analyses not adjusted for multiple testing, one IL6 polymorphism (rs6949149) was marginally associated with breast cancer risk (TT versus GG, odds ratios (OR): 1.32; 99% confidence intervals (CI): 1.00-1.74, P(trend) = 0.003) and two were marginally associated with prostate cancer risk (rs6969502-AA versus rs6969502-GG, OR: 0.87, 99% CI: 0.75-1.02; P(trend) = 0.002 and rs7805828-AA versus rs7805828-GG, OR: 1.11, 99% CI: 0.99-1.26; P(trend) = 0.007). An increase in breast cancer risk was observed for the PTGS2 polymorphism rs7550380 (TT versus GG, OR: 1.38, 99% CI: 1.04-1.83). No association was observed between PTGS2 polymorphisms and prostate cancer risk. In conclusion, common genetic variation in these two genes might play at best a limited role in breast and prostate cancers.
authors: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany. l.dossus@dkfz.de
authors: Laure
authors: L
authors: Dossus
authors: Rudolf
authors: R
authors: Kaaks
authors: Federico
authors: F
authors: Canzian
authors: Demetrius
authors: D
authors: Albanes
authors: Sonja I
authors: SI
authors: Berndt
authors: Heiner
authors: H
authors: Boeing
authors: Julie
authors: J
authors: Buring
authors: Stephen J
authors: SJ
authors: Chanock
authors: Francoise
authors: F
authors: Clavel-Chapelon
authors: Heather Spencer
authors: HS
authors: Feigelson
authors: John M
authors: JM
authors: Gaziano
authors: Edward
authors: E
authors: Giovannucci
authors: Carlos
authors: C
authors: Gonzalez
authors: Christopher A
authors: CA
authors: Haiman
authors: Göran
authors: G
authors: Hallmans
authors: Susan E
authors: SE
authors: Hankinson
authors: Richard B
authors: RB
authors: Hayes
authors: Brian E
authors: BE
authors: Henderson
authors: Robert N
authors: RN
authors: Hoover
authors: David J
authors: DJ
authors: Hunter
authors: Kay-Tee
authors: KT
authors: Khaw
authors: Laurence N
authors: LN
authors: Kolonel
authors: Peter
authors: P
authors: Kraft
authors: Jing
authors: J
authors: Ma
authors: Loic
authors: L
authors: Le Marchand
authors: Eiliv
authors: E
authors: Lund
authors: Petra H M
authors: PH
authors: Peeters
authors: Meir
authors: M
authors: Stampfer
authors: Dan O
authors: DO
authors: Stram
authors: Gilles
authors: G
authors: Thomas
authors: Michael J
authors: MJ
authors: Thun
authors: Anne
authors: A
authors: Tjonneland
authors: Dimitrios
authors: D
authors: Trichopoulos
authors: Rosario
authors: R
authors: Tumino
authors: Elio
authors: E
authors: Riboli
authors: Jarmo
authors: J
authors: Virtamo
authors: Stephanie J
authors: SJ
authors: Weinstein
authors: Meredith
authors: M
authors: Yeager
authors: Regina G
authors: RG
authors: Ziegler
authors: David G
authors: DG
authors: Cox
mesh_terms: D000230:Adenocarcinoma / Q000453:epidemiology / Q000235:genetics*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D016022:Case-Control Studies; D002908:Chronic Disease; D015331:Cohort Studies; D051546:Cyclooxygenase 2 / Q000235:genetics*; D005006:Ethnicity / Q000235:genetics / Q000706:statistics & numerical data; D005060:Europe / Q000453:epidemiology; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007249:Inflammation / Q000235:genetics; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000235:genetics*; D012306:Risk; D014481:United States / Q000453:epidemiology
chemical_list: C508600:IL6 protein, human; D015850:Interleukin-6; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human